Clinical Trials
2 trialsNCT05199584 2026-03-05
A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Phase 2 Completed
NCT00306683 2011-02-18
Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed